Breaking News on Global Pharmaceutical Technology & Manufacturing

On the road > Achema 2012 in Frankfurt

New filtration tech boosts biomanufacturing yields, says Sartorius

By Natalie Morrison+

26-Jun-2012

Loading...

Sartorius Stedim says its new range of sterilising-grade filters can allow steam cleaning in dry conditions and minimises protein binding.

The cartridges, launched under the Sartipore Platinum banner, combines two new technology platforms which together allow for greater wettability in filtration for biomanufacturing.

Firstly, the modified PES (polyethersulfone hydrophilic membrane) is chemically bonded to the surface of the molecule, rather than just stuck to it as previous methods saw. The uptick is that the membrane can withstand extremely high temperatures, and therefore cannot be flushed out during steaming.

Secondly, the twin pleating technology is a new way of pleating the membrane which increases its area by more than 60 per cent.

Speaking to told in-PharmaTechnologist.com at this year’s Achema, product manager for filtration technologies, Jens Meyer said: “With these new technologies it is possible to wet a 10 inch cartridge using only 2 litres of flushing volume, which is really drastic reduction of WFI (water for injection) consumption by about 95 per cent compared to other cartridges.

“You can wet them in wet and dry conditions from both directions, and it has the lowest unspecific protein binding for any PES membrane on the market. It’s really a big step in filtration tech and clearly defines a new benchmark for filtration.”

He added that the launch is a response to high customer demand for the ability to steam cartridges.

“Many customers want to use the steaming procedure to sterilise cartridges in a dry condition. This is really complicated for many cartridges on the market, but with the Sartipore Platinum we can.”

He added: “It has the lowest extractables and leachables level of any other membrane on the market.”

From cradle to market

The platform is also fully scalable with cartridges from R&D (research and development) to big processing scale available.

“Customers have less efforts for process validation, they can use the  same material the same kind of filter from the very beginningwithout any change of membrane,” Meyer added.

Related products

Related suppliers

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

John Giannone - incoming IPEC-Americas chairman

Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Special Report from ATMI's Belgian Facility

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

Walter Dissinger

President , BASF nutrition and health

Optimism is returning to the pharma fine chemicals sector, says analyst

Optimism is returning to the pharma fine chemicals sector, says analyst

Jan Ramakers

Industry consultant, Jan Ramakers Fine Chemical Consulting Group

Capsugel expands liquid fill capsule capabilities

Keith Hutchison,

Senior VP of research and development (R&D) , Capsugel

New filtration tech boosts biomanufacturing yields, says Sartorius

New filtration tech boosts biomanufacturing yields, says Sartorius

Jens Meyer

Product manager for filtration technologies, Sartorius Stedim

Submit good REMS proposals for FDA brownie points, says RAPS author

Submit good REMS proposals for FDA brownie points, says RAPS author

Ed Tabor

VP of strategic drug development , Quintiles

Initial investment in REMS means big pay-put for pharma, says RAPS author

Initial investment in REMS means big pay-put for pharma, says RAPS author

Ed Tabor

VP of strategic drug development , Quintiles

The single-use age has dawned, says ThermoFisher

The single-use age has dawned, says ThermoFisher

Bill Whitford

Senior manager of the bioprocessing market , ThermoFisher

 Fette's 'common sense' approach to boosting production

Fette's 'common sense' approach to boosting production

Jim Mossop

New business and project manager, Fette Compacting

Create painless devices for quicker regulatory approval, says BD

Create painless devices for quicker regulatory approval, says BD

Joel Cotten

European product manager of pharmaceutical systems, BD

Unilife launches Autoinfuser range publically

Unilife launches Autoinfuser range publically

Stephen Allan

VP of marketing and communications , Unilife

Aptar Pharma says new eDevices will speed up regulatory approval

Aptar Pharma says new eDevices will speed up regulatory approval

Joachim Koerner

VP of eDevice R&D, prescription division, , Aptar Pharma

Excipact scheme to launch next week

Excipact scheme to launch next week

Excipient makers could save up to 200 man hours with a new industry-driven, third-party...

Cargill stresses importance of cost- efficient taste masking in drug manufacturing

Cargill stresses importance of cost- efficient taste masking in drug manufacturing

Bénédicte Pascalie

category marketing manager, Cargill Flavor Systems

The future of HPAPIs according to industry insiders

The future of HPAPIs according to industry insiders

Allan Clarke and Radha Srikrishna Maganti

GSK and Dr Reddy's

Endeavour creates new intermediates for prion drug developers

Endeavour creates new intermediates for prion drug developers

Jordi Robinson

Sales manager chemical intermediates, Endeavour Specialty Chemicals

BASF talks excipients, raw materials and development plans at CPhI 2011

BASF talks excipients, raw materials and development plans at CPhI 2011

Ralf Fink

VP global marketing pharma ingredients, BASF

Excipact auditing certification scheme explained

Excipact auditing certification scheme explained

Iain Moore

Excipact Project Coordinator, Croda

Continuous manufacturing offers QbD and PAT advantages says ISP

Continuous manufacturing offers QbD and PAT advantages says ISP

Dr Stuart Porter

Senior Director Global Pharmaceutical Applications R&D, ISP

LB Bohle sees increasing demand for ‘try before you buy’ demos

Martin Hack

VP and general manager, LB Bohle LLC

EMD Millipore talks integration: of processes; and with owner Merck KGaA

EMD Millipore talks integration: of processes; and with owner Merck KGaA

Paul Chapman

Head of Biopharm Process Solutions, EMD Millipore

UNCTAD to discuss fostering drug manufacturing in Africa

UNCTAD to discuss fostering drug manufacturing in Africa

Christoph Spennemann

Intellectual Property Unit Investment Capacity-Building Branch, UNCTAD Division on Investment...

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Missy Lowery

Marketing Manager for the Americas, Capsugel

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Cory Stevenson & Brandon Pence

Thermo Fisher Scientific

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

Eric Isberg

Global Product Manager, ATMI

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the...

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace...

Freeman updates powder analysis tech

Freeman updates powder analysis tech

Tim Freeman

CEO, Freeman Technology

ATMI gears up for single-use "boom" for biotech industry

ATMI gears up for single-use "boom" for biotech industry

Brent Todd

Regional sales manager, ATMI

Mettler Toledo take track and trace offering to the US

Mettler Toledo take track and trace offering to the US

Janice Wortham

Regional sales manager, pharmaceutical, Mettler Toledo

Open pharma – regulator talks “critically important” to ending shortages; FDA

Open pharma – regulator talks “critically important” to ending shortages; FDA

Jeffrey Baker

Deputy Director, Office of Biotechnology Products, CDER, FDA

Fantastic four pool together to create super suite for processing HP drugs

Various

Various, Schenck Accurate, PSL, Malvern, Sturtevant

P-Gels mean cheaper and more varied drug development, says Patheon

P-Gels mean cheaper and more varied drug development, says Patheon

Geoff Glass

VP of sales and marketing, Patheon

Mergers a “key problem” for regulatory compliance, drug quality expert says

Mergers a “key problem” for regulatory compliance, drug quality expert says

Rosario Quintero-Vives

Senior Regulatory & Compliance Specialist, RQV Consultants

EMD Millipore stresses ease of use and flexibility benefits of new bioreactor

EMD Millipore stresses ease of use and flexibility benefits of new bioreactor

Mani Krishnan

director Mobius single-use processing systems, EMD Millipore

PTI stresses benefits of non-destructive testing at Interphex

PTI stresses benefits of non-destructive testing at Interphex

Oliver Stauffer

VP Inspection Technologies, PTI, LLC

in-Pharmatechnologist.com's review of Interphex 2012

in-Pharmatechnologist.com's review of Interphex 2012

in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our...

in-Pharmatechnologist @ Interphex 2012

in-Pharmatechnologist @ Interphex 2012

In-Pharmatechnologist.com has chosen Interphex - the drug industry’s biggest production and processing technology show...

Parexel discusses transdermal drug delivery techs

Parexel discusses transdermal drug delivery techs

Ravi Harapanhalli

Principal Consultant and Practice Lead for Late Stage Product Development...

“Fear of the unknown” limiting adoption of real-time release testing, FDA says

“Fear of the unknown” limiting adoption of real-time release testing, FDA says

Christine Moore

Acting Director, Office of New Drug Quality Assessment, FDA

FDA developing QbD examples to ready generic industry for 2013 deadline

FDA developing QbD examples to ready generic industry for 2013 deadline

Lawrence Yu

Deputy Director, Science and Chemistry, FDA

Pfizer & Bend collaborating on osteoarthritis nanoparticle drug delivery

Pfizer & Bend collaborating on osteoarthritis nanoparticle drug delivery

Michael Morgan

Director of New Technologies, Bend Research

ImQuest Biosciences launches ARV delivery patch at AAPS

ImQuest Biosciences launches ARV delivery patch at AAPS

Anthony Ham

Lead researcher, ImQuest

DSA talks social media in pharma at DIA 2011

DSA talks social media in pharma at DIA 2011

Elizabeth Garrard

Chief Safety Officer, DSA

Bio-Rad rolls out benchtop biomanufacturing tech at Interphex 2011

Bio-Rad rolls out benchtop biomanufacturing tech at Interphex 2011

Kim Brisack

Scientist, Bio-Rad Laboratories